Articles

There’s Too Little Charge to Power a Squeeze for Lucid Stock

I wouldn't count on speculative frenzy alone drive a squeeze, don't count on improved results either to do so either for LCID stock. Resist the urge to buy on "squeeze appeal," and stay away instead.

This A-Rated Company Could Be the Best EV Stock Right Now

Missed out on the huge gains in EV stocks? You might get another chance with BLBD stock as Blue Bird is a rapid revenue grower.

Volatility Continues as Fed Hawks Remain in Control – Here’s What to Do

In today’s Market 360, I’m going to review the five factors that are affecting the market and then share where you should be focusing your energy…

7 A-Rated Biotech Stocks for Your August Buy List

Investing in biotech stocks means accepting a long R&D window, but the rewards when your A-rated biotech stocks come through are huge.

Why This Hyped Renewable Energy Stock Is Not Worth the Gamble

Feel free to take a second look if the story changes, but until then, staying away is your best move with BE stock.

Ignore WeWork’s Phantom Rallies and Avoid WE Stock Like the Plague

After WeWork released a "going concern" warning, WE stock traders should have stayed away. Yet, the shares still rally sometimes.

Don’t Count Out SOFI: Why This Fintech Giant Remains a Long-Term Bet

With its myriad of strengths in mind, there's ample reason to go against the grain with SOFI stock.

AMC Stock Forecast: Even Barbie Can’t Save AMC Entertainment

AMC Entertainment's apparent victory in court wasn't well-received by AMC stock investors as share-dilution concerns persist.

The AI Panic Is Coming: Be Ready

In today’s Market360, we’ll reveal the real reason why the PPI disappointed this week. We’ll also review the CPI numbers, and I’ll explain why the latest inflation data is so important.

Will Tilray’s Beverage Bet Cause Brew Up a Boom or Bust for TLRY Stock?

Weighing the good against the bad with the beverage deal, consider it best to fade the "merger mania," and stay away from TLRY stock.

Palantir’s Upside: Should PLTR Stock Investors Double Down Now?

There may be a buying opportunity as PLTR stock tumbled despite Palantir Technologies' decent quarterly results.

Weekly Upgrades and Downgrades

During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start.

Watch and Wait! The Optimal AI Stock Entry Point Isn’t Here Yet.

'Watch and wait' with AI stock. Pretty soon, a better entry point ($20 per share, or even lower) could arrive.

Quantum Computing Play IONQ Is the Silent Giant for Next-Gen AI

IONQ stock has the potential to continue its powerful rally as IonQ proves itself as a pioneer of AI-adjacent computing technology.

The Latest Inflation Report Disappoints – but There Are Still Ways to Profit

In today’s Market360, we’ll reveal the real reason why the PPI disappointed this week. We’ll also review the CPI numbers, and I’ll explain why the latest inflation data is so important.

What NVIDIA’s New Superchip Means for the Future of AI

In today’s Market 360, let’s dive into NVIDIA’s blockbuster news – and what it means for the future of AI. We’ll also review Wall Street’s lackluster response to the new superchip, and I’ll explain why NVIDIA remains a great buy right now.

7 F-Rated Dividend Stocks to Dump ASAP

There's no reason for bad dividend stocks to drag your portfolio down. If you're holding onto one of these names, it's time to let them go.

CMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.

While the story could change down the road, for now your best move is to avoid CMRX stock, even as a small, speculative position.

The PayPal Paradox: CEO Confidence Is No Match for PYPL Stock Hard Data

Once a high flyer, PYPL stock has been brought down to earth and could continue falling as PayPal's margins come under pressure.